| |
| |
|
| Insider
Information: |
Howson Tamar D |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
221,596 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,512,041 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
221,596 |
|
|
| Total
Value |
$3,512,041 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP, Corp & Bus Develo... |
2006-12-01 |
71,465 |
2003-09-10 |
0 |
Premium* |
|
|
Mateon Therapeutics Inc |
MATN |
Director |
2013-07-01 |
8,761 |
2010-04-02 |
0 |
Premium* |
|
|
Aradigm Corp |
ARDM |
Director |
2012-05-25 |
132,331 |
2010-11-03 |
0 |
Premium* |
|
|
Warner Chilcott Ltd |
WCRX |
Director |
2013-09-30 |
0 |
2013-05-07 |
0 |
Premium* |
|
|
Allergan plc |
AGN |
Director |
2015-03-17 |
1,539 |
2013-10-01 |
0 |
Premium* |
|
|
Organovo Holdings, Inc. |
ONVO |
Director |
2016-08-17 |
7,500 |
2016-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONVO |
Organovo Holdings, Inc. |
Director |
– • – |
2016-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2015-03-17 |
4 |
D |
$307.51 |
$168,823 |
D/D |
(549) |
1,539 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2014-05-09 |
4 |
A |
$197.05 |
$225,031 |
D/D |
1,142 |
2,088 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2013-11-06 |
4 |
S |
$157.34 |
$47,202 |
D/D |
(300) |
946 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2013-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,246 |
1,246 |
0 |
- |
|
| WCRX |
Warner Chilcott Ltd |
Director |
– • – |
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,170) |
0 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,703 |
8,761 |
0 |
- |
|
| WCRX |
Warner Chilcott Ltd |
Director |
– • – |
2013-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,170 |
4,170 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,886 |
5,058 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,148 |
38,060 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2012-07-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
18,148 |
38,060 |
0 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2012-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
132,331 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2011-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,061 |
9,811 |
0 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2011-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
39,474 |
82,331 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2011-01-02 |
4 |
A |
$0.23 |
$5,750 |
D/D |
25,000 |
75,000 |
0 |
- |
|
| ARDM |
Aradigm Corp |
Director |
– • – |
2010-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
42,857 |
42,857 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2010-07-01 |
4/A |
A |
$0.38 |
$9,503 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2010-07-01 |
4 |
S |
$0.39 |
$9,750 |
D/D |
(25,000) |
50,000 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
Director |
– • – |
2010-04-02 |
4 |
A |
$1.17 |
$29,250 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Corp & Bus Development |
• – – |
2006-12-01 |
4 |
D |
$24.74 |
$75,160 |
D/D |
(3,038) |
71,465 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Corp & Bus Development |
• – – |
2006-09-08 |
4 |
D |
$22.96 |
$27,896 |
D/D |
(1,215) |
74,503 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Corp & Bus Development |
• – – |
2006-05-22 |
4 |
D |
$24.16 |
$73,398 |
D/D |
(3,038) |
75,718 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Corp & Bus Development |
• – – |
2006-03-07 |
4 |
D |
$22.73 |
$42,323 |
D/D |
(1,862) |
78,756 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Corp & Bus Development |
• – – |
2006-03-07 |
4 |
A |
$22.73 |
$299,854 |
D/D |
13,192 |
80,618 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2005-12-02 |
4 |
D |
$21.69 |
$71,447 |
D/D |
(3,294) |
67,426 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
